A 45-year-old man with diabetes and hypertension presents for cardiovascular risk assessment. He is a non-smoker with LDL-C 2.9 mmol/L, HDL-C 1.1 mmol/L, triglycerides 1.5 mmol/L. His 10-year ASCVD risk is estimated at 18%. According to the 2021 Canadian Cardiovascular Society dyslipidaemia guideline, what is the most appropriate lipid-lowering strategy?